Bid Alert No: 00000575166
Bid Title: Sole source notice for Photrexa KXL System.
Agency Bid No. Title: 3150000503
Received Date: 05/18/2016
Close Date: 05/31/2016
Purchase Type: Not Stated
Delivery Point: University of Mississippi Medical Center, Jackson, Mississippi
Delivery Date: Not Stated
Specifications include, but are not limited to: The University of Mississippi Medical Center (UMMC) seeks to purchase PhotrexaViscous (riboflavin 5-phosphate in 20% dextran ophthalmic solution) 0.146%, Photrexa(riboflavin 5-phosphate ophthalmic solution) 0.146%, and the KXL system (Avedro,Waltham, Massachusetts, USA). This system is the first and only FDA-approvedtherapeutic treatment for progressive keratoconus, a degenerative corneal condition withhigh prevalence in Mississippi, especially in rural areas and among African-Americanpatient population. The KXL system provides an excellent non-invasive alternative tothe treatment of this progressive disease.
Bid Related DocumentsDownload Document
Product Code: 46537
Issuing Agency: University of Mississippi Medical Center (UMMC)
Agency Type: State and Local